Molecular Mechanism of Cholerae Toxin (Ctx) in Causing Diarrhea by Praja, R. K. (Rian) & Rosalina, R. (Reny)
LITERATURE STUDY Oceana Biomedicina Journal    Vol 1 No 2 
            Jul – Dec 2018 
116 
 
Molecular Mechanism of Cholerae Toxin (ctx) in Causing Diarrhea 
 
Rian Ka Praja1 and Reny Rosalina2 
 
1Alumnus of Master Program in Biomedicine, Faculty of Medicine, Udayana University 
Jl. PB. Sudirman, Denpasar, Bali. 
2Institut Ilmu Kesehatan Bhakti Wiyata Kediri 
Jl. KH. Wahid Khasyim No. 65, Kediri, East Java 
*Corresponding author: riankapraja@gmail.com 
 
ABSTRACT 
Vibrio cholerae is one of the pathogenic bacteria transmitted through contaminated 
food, especially contaminated seafood and beverages. V. cholerae produces cholerae toxin 
(ctx) which is encoded by the ctx gene located within its chromosome. This toxin has been 
recognized as one of the toxins responsible for cholera outbreaks. The mechanism of ctx gene 
expression is induced by environmental signals such as pH, osmolarity, temperature, bile, 
amino acids, and CO2. These signals will be a positive transcriptional factor to the ToxR gene 
that regulates the biogenesis of cholerae toxin. After cholerae toxin has been successfully 
expressed, V. cholerae uses a type II secretion (T2S) pathway to deliver cholerae toxin to the 
extracellular environment. Cholerae toxin consists of A and B subunits. The B subunit plays 
a role in attaching to the receptor Manosialosyl Ganglioside (GM1 ganglioside) and the A 
subunit plays a role in catalyzing ADP-ribosylation of Gs (stimulatory) protein and turning 
them into active condition. The Gs protein will convert the inactive adenilate cyclase (AC) 
into active AC. The increase of AC activity will increase the cyclic adenosine 3'5'-
monophosphate (cAMP) concentration along the cell membrane. The cAMP then causes the 
active secretion of sodium (Na+), chloride (Cl-), potassium (K+), bicarbonate (HCO3
-), and 
water (H2O) out of the cell into the intestinal lumen, resulting in large fluid losses and 
electrolyte imbalances. 
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INTRODUCTION 
 Cholera is one of the public health problems in developing countries such as Africa, 
Asia and South America, although epidemiologically and bacteriologically cholera has been 
known since the last century (Lesmana, 2004; Ryan and Ray, 2004). The most prominent 
clinical features of cholera are the production of large amounts of liquid feces and the 
occurrence of dehydration as a result of fluid loss through feces. The incubation period of 
cholera can range from several hours to several days depending on the number of inoculum 
(Lesmana, 2004). 
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Vibrio cholerae can be divided into two types based on its pathogenicity, V. cholerae 
serogroup O1 / O139 and V. cholerae serogroup non-O1 / non-O139. Prior to 1992, only V. 
cholerae O1 was known to produce cholerae toxin and was the cause of endemic and 
epidemic outbreaks. Later, V. cholerae O139 is also known to produce toxins in quantities as 
large as serogroup O1 (Faruque, 1998, Pal, 2014). Today, V. cholerae serogroup O1 and 
O139 are considered to be pathogenic Vibrio groups that produce cholerae toxin (Dziejman et 
al., 2002; Ryan and Ray, 2004; Olaniran et al., 2011). 
Cholerae toxin is a major toxin responsible for the occurrence of diarrhea in cholera 
outbreaks. This toxin is considered as a major virulence factor. Therefore, the ctx gene is 
often used to determine the pathogenicity of V. cholerae (Chen et al., 2004; Chomvarin et al., 
2007; Huq et al., 2012). This review will discuss the molecular mechanism of cholerae toxin 
in causing diarrhea. 
 
THE STRUCTURE OF CHOLERAE TOXIN 
Vibrio cholerae produces a heat-labile enterotoxin with a molecular weight of about 
84,000 Dalton comprising A and B subunits (Figure 1) (Wernick et al., 2010; Brooks et al., 
2013). Cholerae toxin is a toxin responsible for cholera. The cholerae toxin belongs to 
pathogenic V. cholerae which is encoded by the ctxA and ctxB genes (Faruque, 1998; 
Maheshwari et al., 2011).  
 
Figure 1. The three-dimensional structure of cholera toxin (ctx) (Wernick et al., 2010). 
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The both of subunits have different functions, B subunit is responsible for binding on 
the Manosialosyl Ganglioside (GM1 Ganglioside) and A subunit is an active subunit that 
activates adenilate cyclase in small intestinal epithelial cells (Maheshwari et al., 2011). The 
A subunit is divided into A-1 chain and A-2 chain, between A and B subunits are connected 
with disulfide bond (Wernick et al., 2010). 
 
EXPRESSION AND SECRETION OF CHOLERAE TOXIN 
The expression of the virulence genes is a major factor contributing to the 
pathogenicity of V. cholerae. Some of the virulence factors of V. cholerae include ToxR 
regulator, cholerae toxin (ctxA and ctxB), toxin-coregulated pilus subunit (TcpA), outer 
membrane protein U (ompU), outer membrane protein W (ompW), accessory cholerae 
enterotoxin (Ace), and zonular occludens toxin (Zot) (Reidl and Klose, 2002; Waturangi et 
al., 2013; Ramazanzadeh et al., 2015). The expression of V. cholerae virulence factor is 
controlled by ToxR regulatory cascade which depends on environmental conditions (Figure 
2) (Raskin et al., 2004; Schild et al., 2008). 
 
Figure 2. The mechanism of ctx gene activation (Raskin et al., 2004). 
 
In vivo, signals which can activate the ToxR gene are still unclear, but in vitro, several 
environmental signals such as pH, osmolarity, temperature, bile, amino acids, and CO2 can 
activate the ToxR gene. These signals will be a positive transcriptional activator of ToxRS and 
TcpPH, which then activates the expression of toxT which is another positive transcriptional 
activator. ToxT is a protein that directly activates the biogenesis of TCP genes as well as 
ctxAB expression (Raskin et al., 2004). 
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 Once the toxin is successfully expressed, the toxin should be secreted out to cause a 
disease. Most Gram-negative bacteria use the type II secretion (T2S) pathway to deliver 
proteins that contribute to the emergence of a disease (Korotkov et al., 2012; Green and 
Mecsas, 2016). The T2S system consists of two main lines: general secretion (Sec) and twin 
arginine translocation (Tat) pathway (Nivaskumar and Francetic, 2014; Green and Mecsas, 
2016). 
 
Figure 3. The secretion mechanism of the T2S system (Douzi et al., 2012). 
 
Vibrio cholerae uses the T2S system in the cholerae toxin translocation process. In 
the transport process, cholerae toxin secretion uses T2S through two major steps: 
translocation the inner membrane through Sec pathway and is followed by transport of 
folded/oligomeric cargo protein by T2S to the extracellular environment (Douzi et al., 2012; 
Green and Mecsas, 2016). 
 
THE ACTION OF CHOLERAE TOXIN 
A person who has normal stomach acid should swallow 108-1010 organisms in the 
water to get infected and become ill, because the bacteria are very sensitive to the acidic 
environment. If the mediator is food, as many as 102-104 bacteria are needed because of the 
sufficient buffer capacity of the food. Some medications and conditions that may lower the 
acid levels in the stomach make a person more sensitive to V. cholerae infection (Brooks et 
al., 2013). 
Vibrio cholerae colonizes in the intestinal epithelium but is not invasive or causes 
structural changes of the epithelium (Lesmana, 2004). The main effect of V. cholerae 
LITERATURE STUDY Oceana Biomedicina Journal    Vol 1 No 2 
            Jul – Dec 2018 
120 
 
infection is the actively increasing secretion of chloride, sodium, potassium, bicarbonate and 
water. This event occurs through the activity of cholerae toxin (Ryan and Ray, 2004). 
There are very important V. cholerae surface proteins related to the life cycle and 
pathogenesis of cholera, namely N-acetyl-D-glucosamine binding protein (GbpA) and 
hemagglutinin / protease (HapA). GbpA is associated with the ability of V. cholerae to attach 
to the chitin surface and also to the mucin lining the intestinal epithelial cells (Kirn et al., 
2005). Based on molecular analysis, GbpA has 4 domains that generally relate to the ability to 
attach to the chito-oligosaccharides. Additional function of domain 1 is related to attachment 
to mucin while domain 2, 3 along with domain 1 helps bacteria to colonize the rat baby's 
small intestine (Wong et al., 2012). Hemagglutinin / protease (HapA) acts as a proteolytic 
enzyme that can lyse existing substrates in the intestinal environment such as ovomucin, 
fibronectin, and lactoferrin. HapA helps V. cholerae to penetrate more deeply and degrade the 
mucus layer of the intestine. Therefore, cholerae toxin can bind with GM1 ganglioside 
receptors as well as for detachment processes (Sikora, 2013). 
 
 
Figure 4. The action of cholera toxin (Ryan and Ray, 2004). 
 
The complete cholerae toxin consisting of A and B subunits is released by V. cholerae 
and then B subunit binds to GM1 ganglioside receptors on the intestinal epithelial mucosal 
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surface and A subunit which is an active part of the toxin catalyzes ADP-ribosylation of G 
(stimulatory) protein and converts it become active. The Gs protein plays a role in converting 
the inactive adenilate cyclase (AC) into active AC then the increase of AC activity will 
increase the cyclic adenosine 3'5'-monophosphate (cAMP) concentration along the cell 
membrane. Furthermore, cAMP causes active secretion of sodium (Na+), chloride (Cl-), 
potassium (K+), bicarbonate (HCO3
-), and water (H2O) exit from cells to the intestinal lumen 
resulting in large fluid losses and electrolyte imbalances (Ryan and Ray, 2004; Thiagarajah 
and Verkman, 2005; Lima and Fonteles, 2015). The clinical features of cholera are diarrhea 
and the occurrence of dehydration as a result of fluid loss through feces. Diarrhea is often 
followed by vomiting, especially early in the disease and if left untreated can cause death 
(Lesmana, 2004). 
 
CONCLUSION 
Vibrio cholerae O1 and O139 are pathogenic serogroups known to produce cholerae 
toxin which is a major toxin in causing diarrhea in humans. The mechanism in causing 
diarrhea caused by cholera toxin is through increased adenilate cyclase. Since cholerae toxin 
is an important virulence factor, therefore the ctx gene is a target gene that is often used to 
determine the pathogenicity of V. cholerae. 
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